45 results on '"Schmid, Yasmin"'
Search Results
2. Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study
3. Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries
4. Krampfanfall nach schwerer Asthmaexazerbation
5. Crise convulsive après une exacerbation sévère de l'asthme
6. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders
7. Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
8. Finding CYP2D6 activity biomarkers by correlating MDMA pharmacokinetic parameters to untargeted metabolomics data
9. Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
10. SOP Paracetamolintoxikation
11. Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis
12. Acute subjective effects in LSD- and MDMA-assisted psychotherapy
13. Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland
14. Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adults
15. Verdacht auf K.o.-Mittel: Diagnostik in der Notfallstation und Praxis
16. Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distribution
17. Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal film
18. Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set
19. Sex differences in the pharmacology of itch therapies—a narrative review
20. Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
21. Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions
22. Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes
23. Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing
24. Long-lasting subjective effects of LSD in normal subjects
25. First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects
26. Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects
27. Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
28. Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
29. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
30. Alterations of consciousness and mystical-type experiences after acute LSD in humans
31. Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images
32. Development and validation of an ultra‐fast and sensitive microflow liquid chromatography‐tandem mass spectrometry (MFLC‐MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans
33. CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals
34. LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
35. Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans
36. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
37. Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans
38. Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
39. Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects
40. Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships
41. Differential effects of MDMA and methylphenidate on social cognition
42. Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects
43. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation
44. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination
45. MDMA enhances emotional empathy and prosocial behavior
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.